PBGH Survey Finds Employers Bracing for Higher Health Premiums in 2026

Why It Matters

Rising premiums threaten employer budget stability and talent retention, making transparent, data‑driven benefit procurement essential for fiduciary success. The legislative focus on PBM oversight accelerates industry shifts toward cost accountability and innovative purchasing models.

Key Takeaways

• Premiums projected to rise 6‑7% in 2026, some plans >20%
• 37% of employers launching medical RFPs; 23% pursuing pharmacy RFPs
• 27% already using non‑traditional pharmacy benefit managers
• Consolidated Appropriations Act 2026 expands PBM transparency and oversight
• PBGH members spend $350 billion covering 21 million workers

Pulse Analysis

Employers are confronting a steep climb in health‑care costs, with the PBGH survey flagging a 6‑7% premium increase for 2026 and outlier plans surging beyond 20%. This pressure is not merely a line‑item issue; it ripples through compensation packages, talent acquisition, and overall competitiveness. As payroll budgets tighten, executives are demanding clearer pricing signals and evidence that higher spend translates into better health outcomes. The survey underscores that lack of price transparency remains a core obstacle, prompting a strategic pivot toward data‑rich decision making.

In response, a growing share of large employers are overhauling their benefit procurement processes. Over a third are issuing medical RFPs, while nearly a quarter are doing the same for pharmacy benefits, signaling a shift from legacy contracts to competitive, value‑based arrangements. Adoption of non‑traditional pharmacy benefit managers—now at 27% among respondents—reflects a willingness to explore alternative models that promise lower drug spend and greater formulary control. The Consolidated Appropriations Act 2026 further fuels this momentum by mandating PBM transparency, giving employers access to pricing and quality metrics previously hidden behind proprietary systems.

The convergence of legislative pressure and employer activism is reshaping the health‑benefits market. With $350 billion in annual spend and 21 million lives at stake, insurers and PBMs must adapt to a landscape where price, quality, and accountability are scrutinized in tandem. Companies that leverage bundled payments, direct‑provider contracts, and centers‑of‑excellence stand to mitigate cost growth while enhancing employee health. For decision‑makers, the imperative is clear: invest in robust data platforms, align with partners committed to transparency, and embed fiduciary rigor into every benefit strategy to stay ahead of the premium surge.